Cll-nhl.com

Search Preview

Dr. Sharman's CLL & Lymphoma Blog

www.cll-nhl.com/

blog about CLL (chronic lymphocytic leukemia) and NHL (non hodgkin's lymphoma), prognosis, chemotherapy, survival, treatment,

Most Used Html Elements

  • <div> : 318
  • <a> : 266
  • <span> : 236
  • <li> : 138
  • <img> : 63
  • <br> : 51
  • <ul> : 51
  • <script> : 20
  • <h2> : 17
  • <link> : 11
  • <meta> : 10
  • <td> : 7
  • <input> : 6
  • <table> : 3
  • <abbr> : 3
  • <h3> : 3
  • <tr> : 3
  • <form> : 2
  • <tbody> : 2
  • <style> : 2
  • <aside> : 2

Most Used Html Classes

  • "post-count-link" : 45
  • "archivedate" : 45
  • "hierarchy" : 45
  • "post-count" : 45
  • "zippy" : 45
  • "toggle" : 45
  • "collapsed" : 43
  • "clear" : 35
  • "blog-admin" : 21
  • "item-control" : 21
  • "cap-left" : 20
  • "widget" : 20
  • "cap-right" : 20
  • "feed-icon" : 18
  • "feed-reader-link" : 18
  • "quickedit" : 17
  • "widget-item-control" : 17
  • "widget-content" : 16
  • "subscribe" : 15
  • "top" : 12
  • "inner" : 12
  • "subscribe-dropdown-a..." : 12
  • "bottom" : 12
  • "section" : 11
  • "fauxborder-right" : 10
  • "cap-top" : 10
  • "cap-bottom" : 10
  • "fauxborder-left" : 10
  • "post-footer-line" : 9
  • "expanded" : 8
  • "item-snippet" : 7
  • "item-title" : 7
  • "title" : 7
  • "feed-reader-links" : 6
  • "subscribe-type-comme..." : 6
  • "subscribe-wrapper" : 6
  • "subscribe-type-post" : 6
  • "foot" : 5
  • "fauxcolumn-inner" : 5
  • "fauxcolumn-outer" : 5
  • "region-inner" : 4
  • "addthis_counter" : 3
  • "post-footer" : 3
  • "entry-content" : 3
  • "addthis_pill_style" : 3
  • "addthis_button_pinte..." : 3
  • "addthis_button_tweet" : 3
  • "entry-title" : 3
  • "post-title" : 3
  • "hentry" : 3
  • "post-header" : 3
  • "post-header-line-1" : 3
  • "addthis_default_styl..." : 3
  • "addthis_toolbox" : 3
  • "addthis_button_faceb..." : 3
  • "post-timestamp" : 3
  • "post-footer-line-2" : 3
  • "icon-action" : 3
  • "post-labels" : 3
  • "post-footer-line-3" : 3
  • "post" : 3
  • "post-location" : 3
  • "pid-1079437367" : 3
  • "columns-cell" : 3
  • "vcard" : 3
  • "post-author" : 3
  • "fn" : 3
  • "timestamp-link" : 3
  • "post-icons" : 3
  • "published" : 3
  • "post-footer-line-1" : 3
  • "post-body" : 3
  • "no-items" : 3
  • "post-outer" : 3
  • "date-outer" : 3
  • "date-header" : 3
  • "date-posts" : 3
  • "toggle-open" : 2
  • "text" : 2
  • "header" : 2
  • "gsc-search-button" : 2
  • "linklist" : 2
  • "gsc-input" : 2
  • "gsc-search-box" : 2
  • "tabs" : 2
  • "navbar" : 2

Where is www.cll-nhl.com hosted?

Country:
United States
City:
Mountain View
Registrar:
Tucows Domains Inc.
Latitude:
37.42
Longitude:
-122.06
IP address:
172.217.16.179
IP Binary address:
10101100110110010001000010110011
IP Octal address:
25466210263
IP Hexadecimal address:
acd910b3

Context analysis of cll-nhl.com

Number of letters on this page:
5 852
Number of words on this page:
1 371
Number of sentences on this page:
47
Average words per sentences on this page:
29
Number of syllables on this page:
2 000

Domain name architecture

Domain name length:
11
Hyphens:
Domain contain 1 hyphens!
Domain name with Hindi letters:
च ल ल - ञ (h) ल . च ओ म
Domain name with Hebrew letters:
ק(c) ל ל - נ ה ל . ק(c) (ο) מ
Domain name with Cyrillic letters:
ц л л - н х л . ц о м
Domain name with Arabic letters:
(c) ل ل - ن ح ل . (c) (o) م
Domain name with Greek letters:
χ λ λ - ν (h) λ . χ ο μ
Domain name with Chinese letters:
西 艾勒 艾勒 - 艾娜 艾尺 艾勒 . 西 哦 艾马
Domain without Consonants:
cll-nhl.cm
Domain without Vowels:
-.o
Alphabet positions:
c3 l12 l12 n14 h8 l12 . c3 o15 m13
Domain name pattern:
V: Vowel, C: Consonant, N: Number
C C C C C C . C V C

<HEAD> DATA INFORMATION

Encoding:
UTF-8
viewport:
width=1100
generator:
blogger
description:
blog about CLL (chronic lymphocytic leukemia) and NHL (non hodgkin's lymphoma), prognosis, chemotherapy, survival, treatment,

External links in cll-nhl.com

  • https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm554698.htm
  • https://www.fda.gov/ForConsumers/ProtectYourself/HealthFraud/ucm533465.htm
  • http://www.pbs.org/wgbh/frontline/film/supplements-and-safety/
  • https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048383.htm
  • https://www.blogger.com/post-edit.g?blogID=3165131923857031708&postID=1586672709327397513&from=pencil
  • https://www.blogger.com/post-edit.g?blogID=3165131923857031708&postID=3189068233666580687&from=pencil
  • https://www.clinicaloptions.com/Oncology/Treatment%20Updates/CLL%20TU/Interactive%20Decision%20Support%20Tool/CLL_Tool.aspx
  • http://www.medscape.org/viewarticle/867859_3
  • http://www.medscape.org/viewarticle/869654
  • https://www.blogger.com/post-edit.g?blogID=3165131923857031708&postID=6127489161753050400&from=pencil
  • https://twitter.com/jeff_sharman
  • http://oregoncancer.com/physicians/profile/jeff-sharman-m.d/
  • http://oregoncancer.com/physicians/profile/jeff-sharman-m.d
  • https://www.google.com/maps/search/willamette+valley+cancer+institute/@44.0734275,-123.0596565,14z/data=!3m1!4b1
  • https://www.usoncology.com/referring-physicians/us-oncology-research
  • http://www.lymphomation.org/index.html
  • http://lymphoma.com/
  • http://cllforum.com/
  • http://health.groups.yahoo.com/group/CLLSLL/
  • http://gotcll.com/
  • http://clltopics.org/index.php
  • http://cllcanada.ca/2010/index.htm
  • http://www.lls.org/content/nationalcontent/resourcecenter/freeeducationmaterials/leukemia/pdf/cll.pdf
  • http://www.lls.org/content/nationalcontent/resourcecenter/freeeducationmaterials/lymphoma/pdf/lymphomaguide.pdf
  • http://leukaemialymphomaresearch.org.uk/sites/default/files/cll_july_2012.pdf
  • http://www.biooncology.com/tumor-types/fnhl/index.html
  • http://www.biooncology.com/tumor-types/dlbcl/index.html
  • http://www.biooncology.com/tumor-types/cll/index.html
  • https://www.netvibes.com/subscribe.php?url=http%3A%2F%2Fwww.cll-nhl.com%2Ffeeds%2Fposts%2Fdefault
  • https://add.my.yahoo.com/content?url=http%3A%2F%2Fwww.cll-nhl.com%2Ffeeds%2Fposts%2Fdefault
  • https://www.netvibes.com/subscribe.php?url=http%3A%2F%2Fwww.cll-nhl.com%2Ffeeds%2Fcomments%2Fdefault
  • https://add.my.yahoo.com/content?url=http%3A%2F%2Fwww.cll-nhl.com%2Ffeeds%2Fcomments%2Fdefault
  • https://www.blogger.com

Internal links in cll-nhl.com

  • http://www.cll-nhl.com/
  • http://www.cll-nhl.com/p/cll-101.html
  • http://www.cll-nhl.com/p/nhl.html
  • http://www.cll-nhl.com/p/wvci-research-abstracts.html
  • http://www.cll-nhl.com/p/cllnhl-doctors.html
  • http://www.cll-nhl.com/p/studies-currently-open-at-wvci.html
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=PageList&widgetId=PageList1&action=editWidget§ionId=crosscol
  • http://www.cll-nhl.com/2017/04/supplement-fraud.html
  • http://www.cll-nhl.com/2013/02/nutritional-supplements.html#.WP-EOfkrKHs
  • http://www.cll-nhl.com/search/label/supplements
  • http://www.cll-nhl.com/2017/04/research-plug.html
  • http://www.cll-nhl.com/2017/02/selecting-therapy-in-cll.html
  • http://www.cll-nhl.com/2013/03/choosing-first-therapy-in-cll.html#.WJIf_1MrKHs
  • http://www.cll-nhl.com/search/label/bendamustine
  • http://www.cll-nhl.com/search/label/CLL%20treatment
  • http://www.cll-nhl.com/search/label/fcr
  • http://www.cll-nhl.com/search/label/ibrutinib
  • http://www.cll-nhl.com/search/label/venetoclax
  • http://www.cll-nhl.com/search?updated-max=2017-02-01T09:51:00-08:00&max-results=3
  • http://www.cll-nhl.com/feeds/posts/default
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=Text&widgetId=Text2&action=editWidget§ionId=sidebar-left-1
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=Image&widgetId=Image1&action=editWidget§ionId=sidebar-left-1
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=Text&widgetId=Text1&action=editWidget§ionId=sidebar-left-1
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=Stats&widgetId=Stats1&action=editWidget§ionId=sidebar-left-1
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=BlogSearch&widgetId=BlogSearch1&action=editWidget§ionId=sidebar-left-1
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=Translate&widgetId=Translate1&action=editWidget§ionId=sidebar-left-1
  • http://www.cll-nhl.com/search/label/11q
  • http://www.cll-nhl.com/search/label/13q
  • http://www.cll-nhl.com/search/label/17p
  • http://www.cll-nhl.com/search/label/Antibody%20Drug%20Conjugate
  • http://www.cll-nhl.com/search/label/atm
  • http://www.cll-nhl.com/search/label/b%20cell%20lymphocytosis
  • http://www.cll-nhl.com/search/label/BCL-2
  • http://www.cll-nhl.com/search/label/BCR%20Signal%20Inhibitor
  • http://www.cll-nhl.com/search/label/birc3
  • http://www.cll-nhl.com/search/label/Brentuximab
  • http://www.cll-nhl.com/search/label/BTK
  • http://www.cll-nhl.com/search/label/CAL-101%20%2F%20GS-1101
  • http://www.cll-nhl.com/search/label/CAR%20T-cells
  • http://www.cll-nhl.com/search/label/cd20
  • http://www.cll-nhl.com/search/label/clinical%20trials
  • http://www.cll-nhl.com/search/label/CLL%20biology
  • http://www.cll-nhl.com/search/label/cll%20prognosis
  • http://www.cll-nhl.com/search/label/clonal%20evolution
  • http://www.cll-nhl.com/search/label/cure
  • http://www.cll-nhl.com/search/label/diffuse%20large%20B%20cell%20lymphoma
  • http://www.cll-nhl.com/search/label/drug%20costs
  • http://www.cll-nhl.com/search/label/drug%20prices
  • http://www.cll-nhl.com/search/label/dying
  • http://www.cll-nhl.com/search/label/entospletinib
  • http://www.cll-nhl.com/search/label/FDA
  • http://www.cll-nhl.com/search/label/FISH
  • http://www.cll-nhl.com/search/label/follicular%20lymphoma
  • http://www.cll-nhl.com/search/label/generic%20drugs
  • http://www.cll-nhl.com/search/label/health%20care%20reform
  • http://www.cll-nhl.com/search/label/holistic%20care
  • http://www.cll-nhl.com/search/label/hospice
  • http://www.cll-nhl.com/search/label/idelalisib
  • http://www.cll-nhl.com/search/label/immunotherapy
  • http://www.cll-nhl.com/search/label/lenalidamide
  • http://www.cll-nhl.com/search/label/lenalidomide
  • http://www.cll-nhl.com/search/label/lymphoma%20biology
  • http://www.cll-nhl.com/search/label/lymphoma%20treatment
  • http://www.cll-nhl.com/search/label/mantle%20cell%20lymphoma
  • http://www.cll-nhl.com/search/label/myc
  • http://www.cll-nhl.com/search/label/notch
  • http://www.cll-nhl.com/search/label/obinutuzumab
  • http://www.cll-nhl.com/search/label/ofatumumab
  • http://www.cll-nhl.com/search/label/off%20label%20drugs
  • http://www.cll-nhl.com/search/label/p53
  • http://www.cll-nhl.com/search/label/personalized%20medicine
  • http://www.cll-nhl.com/search/label/PI3K
  • http://www.cll-nhl.com/search/label/R-CHOP
  • http://www.cll-nhl.com/search/label/Research%20Drugs
  • http://www.cll-nhl.com/search/label/rituximab
  • http://www.cll-nhl.com/search/label/scans
  • http://www.cll-nhl.com/search/label/sf3b1
  • http://www.cll-nhl.com/search/label/stereotype
  • http://www.cll-nhl.com/search/label/syk
  • http://www.cll-nhl.com/search/label/T%20cell%20therapy
  • http://www.cll-nhl.com/search/label/transplant
  • http://www.cll-nhl.com/search/label/trisomy%2012
  • http://www.cll-nhl.com/search/label/videos
  • http://www.cll-nhl.com/search/label/watch%20and%20wait
  • http://www.cll-nhl.com/search/label/zydelig
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=Label&widgetId=Label1&action=editWidget§ionId=sidebar-left-1
  • http://www.cll-nhl.com/2012/10/17p-deletion-in-cll.html
  • http://www.cll-nhl.com/2012/12/when-to-treat-cll.html
  • http://www.cll-nhl.com/2012/12/new-cll-prognostic-groups.html
  • http://www.cll-nhl.com/2012/12/the-slow-indolent-lymphomas.html
  • http://www.cll-nhl.com/2013/01/richters-syndrome-histologic.html
  • http://www.cll-nhl.com/2013/02/nutritional-supplements.html
  • http://www.cll-nhl.com/2014/04/mutated-vs-unmutated-cll.html
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=PopularPosts&widgetId=PopularPosts1&action=editWidget§ionId=sidebar-left-1
  • http://www.cll-nhl.com/2017/
  • http://www.cll-nhl.com/2017/04/
  • http://www.cll-nhl.com/2017/02/
  • http://www.cll-nhl.com/2016/
  • http://www.cll-nhl.com/2016/12/
  • http://www.cll-nhl.com/2016/05/
  • http://www.cll-nhl.com/2016/04/
  • http://www.cll-nhl.com/2016/03/
  • http://www.cll-nhl.com/2015/
  • http://www.cll-nhl.com/2015/12/
  • http://www.cll-nhl.com/2015/11/
  • http://www.cll-nhl.com/2015/06/
  • http://www.cll-nhl.com/2015/05/
  • http://www.cll-nhl.com/2015/02/
  • http://www.cll-nhl.com/2015/01/
  • http://www.cll-nhl.com/2014/
  • http://www.cll-nhl.com/2014/11/
  • http://www.cll-nhl.com/2014/10/
  • http://www.cll-nhl.com/2014/09/
  • http://www.cll-nhl.com/2014/07/
  • http://www.cll-nhl.com/2014/06/
  • http://www.cll-nhl.com/2014/05/
  • http://www.cll-nhl.com/2014/04/
  • http://www.cll-nhl.com/2014/03/
  • http://www.cll-nhl.com/2014/02/
  • http://www.cll-nhl.com/2014/01/
  • http://www.cll-nhl.com/2013/
  • http://www.cll-nhl.com/2013/12/
  • http://www.cll-nhl.com/2013/11/
  • http://www.cll-nhl.com/2013/10/
  • http://www.cll-nhl.com/2013/09/
  • http://www.cll-nhl.com/2013/07/
  • http://www.cll-nhl.com/2013/06/
  • http://www.cll-nhl.com/2013/05/
  • http://www.cll-nhl.com/2013/04/
  • http://www.cll-nhl.com/2013/03/
  • http://www.cll-nhl.com/2013/02/
  • http://www.cll-nhl.com/2013/01/
  • http://www.cll-nhl.com/2012/
  • http://www.cll-nhl.com/2012/12/
  • http://www.cll-nhl.com/2012/11/
  • http://www.cll-nhl.com/2012/10/
  • http://www.cll-nhl.com/2012/09/
  • http://www.cll-nhl.com/2012/08/
  • http://www.cll-nhl.com/2012/07/
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=BlogArchive&widgetId=BlogArchive1&action=editWidget§ionId=sidebar-left-1
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=LinkList&widgetId=LinkList2&action=editWidget§ionId=footer-2-1
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=LinkList&widgetId=LinkList1&action=editWidget§ionId=footer-2-1
  • http://www.cll-nhl.com/feeds/comments/default
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=Subscribe&widgetId=Subscribe3&action=editWidget§ionId=footer-2-2
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=Subscribe&widgetId=Subscribe2&action=editWidget§ionId=footer-2-2
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=Subscribe&widgetId=Subscribe1&action=editWidget§ionId=footer-2-2
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=FollowByEmail&widgetId=FollowByEmail1&action=editWidget§ionId=footer-2-2
  • //www.blogger.com/rearrange?blogID=3165131923857031708&widgetType=Attribution&widgetId=Attribution1&action=editWidget§ionId=footer-3

Possible email addresses for cll-nhl.com

  • info@cll-nhl.com
  • email@cll-nhl.com
  • support@cll-nhl.com
  • contact@cll-nhl.com
  • admin@cll-nhl.com
  • postmaster@cll-nhl.com
  • hostmaster@cll-nhl.com
  • domain@cll-nhl.com
  • abuse@cll-nhl.com

Possible Domain Typos

www.ll-nhl.com, www.cxll-nhl.com, www.xll-nhl.com, www.csll-nhl.com, www.sll-nhl.com, www.cdll-nhl.com, www.dll-nhl.com, www.cfll-nhl.com, www.fll-nhl.com, www.cvll-nhl.com, www.vll-nhl.com, www.c ll-nhl.com, www. ll-nhl.com, www.cl-nhl.com, www.clpl-nhl.com, www.cpl-nhl.com, www.clol-nhl.com, www.col-nhl.com, www.clil-nhl.com, www.cil-nhl.com, www.clkl-nhl.com, www.ckl-nhl.com, www.clml-nhl.com, www.cml-nhl.com, www.cl.l-nhl.com, www.c.l-nhl.com, www.cl-nhl.com, www.cllp-nhl.com, www.clp-nhl.com, www.cllo-nhl.com, www.clo-nhl.com, www.clli-nhl.com, www.cli-nhl.com, www.cllk-nhl.com, www.clk-nhl.com, www.cllm-nhl.com, www.clm-nhl.com, www.cll.-nhl.com, www.cl.-nhl.com, www.cllnhl.com, www.cll-=nhl.com, www.cll=nhl.com, www.cll-_nhl.com, www.cll_nhl.com, www.cll-0nhl.com, www.cll0nhl.com, www.cll-+nhl.com, www.cll+nhl.com, www.cll-*nhl.com, www.cll*nhl.com, www.cll-9nhl.com, www.cll9nhl.com, www.cll-hl.com, www.cll-nbhl.com, www.cll-bhl.com, www.cll-nghl.com, www.cll-ghl.com, www.cll-nhhl.com, www.cll-hhl.com, www.cll-njhl.com, www.cll-jhl.com, www.cll-nmhl.com, www.cll-mhl.com, www.cll-n hl.com, www.cll- hl.com, www.cll-nl.com, www.cll-nhbl.com, www.cll-nbl.com, www.cll-nhgl.com, www.cll-ngl.com, www.cll-nhtl.com, www.cll-ntl.com, www.cll-nhyl.com, www.cll-nyl.com, www.cll-nhul.com, www.cll-nul.com, www.cll-nhjl.com, www.cll-njl.com, www.cll-nhml.com, www.cll-nml.com, www.cll-nhnl.com, www.cll-nnl.com, www.cll-nh.com, www.cll-nhlp.com, www.cll-nhp.com, www.cll-nhlo.com, www.cll-nho.com, www.cll-nhli.com, www.cll-nhi.com, www.cll-nhlk.com, www.cll-nhk.com, www.cll-nhlm.com, www.cll-nhm.com, www.cll-nhl..com, www.cll-nh..com,

More Sites

Acrylic Painting Lessons Online - Berkana Arts
At Berkanaarts.com I offer Acrylic Painting Lessons Online and prints of my artwork for purchase.
Number of used Technologies: 2
Number of used Javascript files: 2
Server Software: DPS/1.1.10
Server Location: United States / Scottsdale - 160.153.136.3
List of used Technologies: CSS (Cascading Style Sheets), Html (HyperText Markup Language), Html5, Javascript
CORTOT Architecture Interieure
Architecte d'interieur à Montrouge. Renovation et conception d'espaces, travaux pour les particuliers et les entreprises.
Number of used Technologies: 2
Number of used Javascript files: 2
Server Software: nginx
Server Location: Ireland / Dublin - 176.34.120.53
List of used Technologies: Google Analytics, CSS (Cascading Style Sheets), Html (HyperText Markup Language), Javascript, CloudFront
マイナンバーカードの保管について
今求められているのはマイナンバーの保管です。
Number of used Technologies: 0
Number of used Javascript files: 0
Server Software: Apache
Server Location: United States / Dallas - 209.164.95.11
List of used Technologies: CSS (Cascading Style Sheets), Html (HyperText Markup Language)
SHADOW.NET
Shadow.net a film about internet movie piracy
Number of used Technologies: 3
Number of used Javascript files: 3
Server Software: Apache
Server Location: United States / Brea - 64.90.40.57
List of used Technologies: CSS (Cascading Style Sheets), Html (HyperText Markup Language), Javascript
italink.com
italink.com
Number of used Technologies: 6
Number of used Javascript files: 6
Server Software: Apache
Server Location: United States / Scottsdale - 68.178.213.61
List of used Technologies: Google Analytics, Google Adsense, CSS (Cascading Style Sheets), Html (HyperText Markup Language), Javascript
Maler Steiner
Number of used Technologies: 4
Number of used Javascript files: 4
Server Software: Apache/2.2.22 (Debian)
Server Location: Austria / Saalfelden - 213.153.32.183
List of used Technologies: CSS (Cascading Style Sheets), Google Font API, Html (HyperText Markup Language), Html5, Javascript, Php (Hypertext Preprocessor)
Wolfgang Ante Photography
Number of used Technologies: 1
Number of used Javascript files: 1
Server Software: Apache/2.4.25
Server Location: Germany / - 80.67.17.84
List of used Technologies: Google Analytics, CSS (Cascading Style Sheets), Html (HyperText Markup Language), Javascript
sinnlos verb(L)oggt
Number of used Technologies: 2
Number of used Javascript files: 2
Server Software: Apache/2.2.3 (CentOS)
Server Location: Germany / - 85.25.68.17
List of used Technologies: Wordpress CMS, CSS (Cascading Style Sheets), Html (HyperText Markup Language), jQuery, Php (Hypertext Preprocessor), Pingback, W3 Total cache
Text Jackpot | Deals Bargins and Free Stuff
Deals Bargins and Free Stuff
Number of used Technologies: 1
Number of used Javascript files: 1
Server Software: nginx/1.12.1
Server Location: United States / Houston - 192.254.233.132
List of used Technologies: Wordpress CMS, Woopra, CSS (Cascading Style Sheets), Feedburner, Google Font API, Html (HyperText Markup Language), Javascript, Php (Hypertext Preprocessor), Pingback, SVG (Scalable Vector Graphics)
Delaware Strong Families | Strong Families… Strong Everything
Delaware Strong Families engages citizens with a biblical worldview to stand for truth and be an active steward of their families, education, and government.
Number of used Technologies: 11
Number of used Javascript files: 11
Server Software: Microsoft-IIS/7.5
Server Location: United States / Houston - 192.232.216.166
List of used Technologies: Wordpress CMS, Google Analytics, CSS (Cascading Style Sheets), Flexslider, Google Font API, Html (HyperText Markup Language), Javascript, jQuery, Php (Hypertext Preprocessor), Pingback